OverviewSuggest Edit

Cancer Genetics, Inc. (CGI) provides DNA-based cancer diagnostics and services to medical institutions. The Company's tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also provide a comprehensive range of non-proprietary oncology-focused tests and laboratory services. CGI’s tests and reference laboratory provide critical genomic information to healthcare professionals as well as biopharma and biotech. The Company's reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited.

TypePublic
Founded1999
HQRutherford, US
Websitecancergenetics.com
Employee Ratings2.4

Latest Updates

Employees (est.) (Dec 2018)150(-31%)
Job Openings13
Revenue (FY, 2018)$27.5 M(-5%)
Share Price (Nov 2019)$2.4 (-11%)

Key People/Management at Cancer Genetics

Jay Roberts

Jay Roberts

Interim Chief Executive Officer & COO

Cancer Genetics Office Locations

Cancer Genetics has offices in Rutherford, Morrisville and Shanghai
Rutherford, US (HQ)
201 Route 17 North
Morrisville, US
133 Southcenter Ct
Shanghai, CN
781 Cai Lun Rd., Rm. 803
Show all (3)

Cancer Genetics Financials and Metrics

Cancer Genetics Revenue

Embed Graph
View revenue for all periods
Cancer Genetics's revenue was reported to be $27.47 m in FY, 2018
USD

Revenue (Q2, 2019)

1.5m

Gross profit (Q2, 2019)

800.0k

Gross profit margin (Q2, 2019), %

52.5%

Net income (Q2, 2019)

(3.8m)

EBIT (Q2, 2019)

(795.0k)

Market capitalization (15-Nov-2019)

5.0m

Closing stock price (15-Nov-2019)

2.4

Cash (30-Jun-2019)

667.0k

EV

4.6m
Cancer Genetics's current market capitalization is $5 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

6.6m10.2m18.0m27.0m29.1m27.5m

Revenue growth, %

54%77%50%

Cost of goods sold

4.9m8.5m14.1m17.1m18.1m18.7m

Gross profit

1.7m1.7m3.9m9.9m11.1m8.7m
Quarterly
USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

1.2m1.8m1.7m1.4m1.5m3.2m4.4m4.2m4.0m6.1m7.0m6.8m7.0m6.6m8.0m7.7m7.0m5.9m6.8m1.5m

Cost of goods sold

1.1m1.3m1.2m1.3m1.5m2.6m3.1m3.1m3.1m4.1m4.3m4.4m4.2m4.0m4.6m5.1m4.9m4.7m4.6m725.0k

Gross profit

148.6k552.4k493.8k140.3k8.6k656.1k1.2m1.1m897.1k2.0m2.7m2.3m2.8m2.6m3.4m2.6m2.2m1.3m2.2m800.0k

Gross profit Margin, %

12%30%29%10%1%20%28%26%22%32%39%34%40%39%43%34%31%22%32%52%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

49.5m25.6m19.5m9.5m9.5m161.0k

Accounts Receivable

1.6m5.0m6.6m11.0m7.0m

Prepaid Expenses

864.6k1.2m2.1m2.7m2.1m

Inventories

USDY, 2019

EV/EBIT

-5.7 x

EV/CFO

-0.9 x

Financial Leverage

7.5 x
Show all financial metrics

Cancer Genetics Online and Social Media Presence

Embed Graph

Cancer Genetics Blogs

Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today announced that it intends to offer and sell, subject to market and other conditio…

Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services

Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses  RUTHERFORD, N.J. and RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2019 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immun…

Cancer Genetics Appoints Glenn Miles as Chief Financial Officer

RUTHERFORD, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) — Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the appointment of Glenn Miles as Chief Financial Officer, effective November 26, 201…

Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China

RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced that it has signed an exclusive distribution agreement with Genecast Biotechnol…

Cancer Genetics Issues Letter to Shareholders

RUTHERFORD, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) — Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the publication of a letter to shareholders from its Chief Executive Officer Jay Robe…

Cancer Genetics and Cellaria Partner on Precision Medicine Tools

Collaboration focused on developing pharmacology models to support biopharma R&D RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) — Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, and Cellaria, LL…
Show more

Cancer Genetics Frequently Asked Questions

  • When was Cancer Genetics founded?

    Cancer Genetics was founded in 1999.

  • Who are Cancer Genetics key executives?

    Cancer Genetics's key executives are Jay Roberts.

  • How many employees does Cancer Genetics have?

    Cancer Genetics has 150 employees.

  • What is Cancer Genetics revenue?

    Latest Cancer Genetics annual revenue is $27.5 m.

  • What is Cancer Genetics revenue per employee?

    Latest Cancer Genetics revenue per employee is $183.1 k.

  • Who are Cancer Genetics competitors?

    Competitors of Cancer Genetics include SAGA Diagnostics, miRdetect and Ezra.

  • Where is Cancer Genetics headquarters?

    Cancer Genetics headquarters is located at 201 Route 17 North, Rutherford.

  • Where are Cancer Genetics offices?

    Cancer Genetics has offices in Rutherford, Morrisville and Shanghai.

  • How many offices does Cancer Genetics have?

    Cancer Genetics has 3 offices.